Huesa-Berral, Carlos http://orcid.org/0000-0003-2290-0176
Withrow, Julia D. http://orcid.org/0000-0001-6265-3355
Dawson, Robert J. http://orcid.org/0000-0002-0984-4088
Beekman, Chris http://orcid.org/0000-0002-0061-5473
Bolch, Wesley E. http://orcid.org/0000-0002-7175-9968
Paganetti, Harald http://orcid.org/0000-0002-6257-2413
Wehrenberg-Klee, Eric http://orcid.org/0000-0002-4712-3986
Bertolet, Alejandro http://orcid.org/0000-0002-9890-693X
Funding for this research was provided by:
Massachusetts General Hospital
Article History
Received: 24 August 2023
Accepted: 8 December 2023
First Online: 29 December 2023
Declarations
:
: Eric Wehrenberg-Klee reports consulting fees from SIRTEX, Embolx, Avenge Biosciences, and Cytosite Bio. He has served on advisory boards for Delcath and Eisai. He is an IDMC member for Replimune. He receives clinical research funding from Boston Scientific. He is grant funded by NCI K08-245257.